sentences:
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting BackgroundIt is critical to monitor changes in vaccine effectiveness against COVID-19 outcomes for various vaccine products in different population subgroups.

MethodsWe conducted a retrospective study in patients [≥]12 years who underwent testing for the SARS-CoV-2 virus from April 1 - October 25, 2021 at urgent care centers in the New York City metropolitan area. Patients self-reported vaccination status at the time of testing. We used a test-negative design to estimate vaccine effectiveness (VE) by comparing odds of a positive test for SARS-CoV-2 infection among vaccinated (n=484,468), partially vaccinated (n=107,573), and unvaccinated (n=466,452) patients, adjusted for demographic factors and calendar time.

ResultsVE against symptomatic infection after 2 doses of mRNA vaccines was 96% (95% Confidence Interval [CI]: 95%, 97%) in the pre-delta period and reduced to 79% (95% CI: 77%, 81%) in the delta period. In the delta period, VE for 12-15-year-olds (85%; [95% CI: 81%, 89%]) was higher compared to older age groups (<65% for all other age groups). VE estimates did not differ by sex, race/ethnicity, and comorbidity. VE against symptomatic infection was the highest for individuals with a prior infection followed by full vaccination. VE against symptomatic infection after the mRNA-1273 vaccine (83% [95% CI: 81%, 84%]) was higher compared to the BNT162b2 vaccine (76% [95% CI: 74%, 78%]) in the delta period. VE after the single-dose Ad26.COV2.S vaccine was the lowest compared to other vaccines (29% [95% CI: 26%, 32%]) in the delta period.

ConclusionsVE against infection after two doses of the mRNA vaccine was high initially, but significantly reduced against the delta variant for all three FDA-approved vaccines.


sentences: A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy COVID-19 convalescent plasma (CCP), a passive polyclonal antibody therapeutic, has exhibited mixed results in the treatment of COVID-19. Given that the therapeutic effect of CCP may extend beyond the ability of SARS-CoV-2-specific antibody binding and neutralization to influence the evolution of the endogenous antibody response, we took a systematic and comprehensive approach to analyze SARS-CoV-2 functional antibody profiles of participants in a randomized controlled trial of CCP treatment of individuals hospitalized with COVID-19 pneumonia where CCP was associated with both decreased mortality and improved clinical severity. Using systems serology, we found that the clinical benefit of CCP is related to a shift towards reduced inflammatory Spike (S) responses and enhanced Nucleocapsid (N) humoral responses. We found CCP had the greatest clinical benefit in participants with low pre-existing anti-SARS-CoV-2 antibody function, rather than S or N antibody levels or participant demographic features. Further, CCP induced immunomodulatory changes to recipient humoral profiles persisted for at least two months, marked by the selective evolution of anti-inflammatory Fc-glycan profiles and persistently expanded nucleocapsid-specific humoral immunity following CCP therapy. Together, our findings identify a novel mechanism of action of CCP, suggest optimal patient characteristics for CCP treatment, identify long-last immunomodulatory effects of CCP, and provide guidance for development of novel N-focused antibody therapeutics for severe COVID-19 hyperinflammation.

labels: infectious diseases


sentences:
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile BackgroundMultiple vaccines against SARS-CoV-2 have been evaluated in clinical trials, but very few include the pediatric population. The inactivated vaccine CoronaVac(R) has shown to be safe and immunogenic in a phase 1/2 clinical trial in a pediatric cohort in China. This study is an interim safety and immunogenicity report of a phase 3 clinical trial for CoronaVac(R) in healthy children and adolescents in Chile.

MethodsParticipants aged 3 to 17 years old received two doses of CoronaVac(R) in a four-week interval. Local and systemic adverse reactions were registered in 699 participants that received the first dose and 381 that received the second dose until December 31st, 2021. Whole blood samples were collected from 148 participants for humoral and cellular immunity analyses.

ResultsThe primary adverse reaction reported after the first and second dose was pain at the injection site. The adverse reactions observed were primarily mild and local, and no severe adverse events were reported. Four weeks after the second dose, a significant increase in the levels of total and neutralizing antibodies was observed. Increased activation of specific CD4+ T cells was also observed four weeks after the second dose. Although antibodies induced by vaccination neutralize variants Delta and Omicron, titers were lower than the D614G variant. Importantly, comparable T cell responses were detected against these variants of concern.

ConclusionsCoronaVac(R) is safe and immunogenic in subjects aged 3-17 years old and is thus likely to confer protection against infection caused by SARS-CoV-2 variants in this target population.


sentences:
Best of intent, worst of both worlds: why sequentially combining epidemiological designs does not improve signal detection in vaccine safety surveillance BackgroundVaccine safety surveillance commonly includes a serial testing approach with a sensitive method for "signal generation" and specific method for "signal validation." Whether serially combining epidemiological designs improves both sensitivity and specificity is unknown.

MethodsWe assessed the overall performance of serial testing using three administrative claims and one electronic health record database. We compared Type I and II errors before and after empirical calibration for historical comparator, SCCS, and the serial combination of those designs against six vaccine exposure groups with 93 negative control and 279 imputed positive control outcomes.

ResultsHistorical comparator mostly had lower Type II error than SCCS. SCCS had lower Type I error than the historical comparator. Before empirical calibration, serial combination increased specificity and decreased sensitivity. Type II errors mostly exceeded 50%. After empirical calibration, Type I errors returned to nominal; sensitivity was lowest when the methods were combined.

ConclusionWe recommend against the serial approach in vaccine safety surveillance. While serial combination produced fewer false positive signals compared to the most specific method, it generated more false negative signals compared to the most sensitive method. Using the noisy historical comparator in front of SCCS deteriorated overall performance in evaluating safety signals.

Key MessagesO_LIUsing the serial approach in vaccine safety surveillance did not improve overall performance: specificity increased but sensitivity decreased.
C_LIO_LIWithout empirical calibration, Type II errors exceeded 50%; after empirical calibration, Type I error rates returned to nominal with negligible change to Type II error rates.
C_LIO_LIWhile prior research has suggested high sensitivity of the historical comparator method in distinguishing true safety signals, there were cases when self-controlled case series was more sensitive.
C_LIO_LIVaccine safety surveillance is becoming increasingly important, so monitoring systems should closely consider the utility and sequence of epidemiological designs.
C_LI

labels: epidemiology


sentences:
MEDIAL FRONTAL CORTEX GAMMA-AMINOBUTYRIC ACID CONCENTRATIONS IN PSYCHOSIS AND MOOD DISORDERS: A META-ANALYSIS OF PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDIES BackgroundAbnormalities of gamma-aminobutyric acid-ergic (GABAegic) systems may play an important role in psychosis spectrum and mood disorders. Proton magnetic resonance spectroscopy allows for non-invasive in vivo quantification of GABA; however, studies of GABA in psychosis have yielded inconsistent findings. This may stem from grouping together disparate voxels from functionally heterogeneous regions.

MethodsWe searched the PubMed database for magnetic resonance spectroscopy studies of medial frontal cortex (MFC) GABA in patients with psychosis, bipolar disorder, depression, and individuals meeting ultra-high risk for psychosis criteria. Voxel placements were classified as rostral-, rostral-mid-, mid-, or posterior MFC, and random effects meta-analyses conducted for each group, for each MFC sub-region.

ResultsOf 341 screened articles, 23 studies of psychosis (752 patients,856 controls), 6 studies of bipolar disorder (129 patients, 94 controls), 20 studies of depression (463 cases, 449 controls) and 7 studies of ultra-high risk (229 patients, 232 controls) met inclusion criteria. Meta-analysis revealed lower mid-(SMD = -0.28, 95% confidence interval [CI] = -0.48 to -0.07, p < .01) and posterior (SMD = -0.29, 95% CI = -0.49 to -0.09, p <.01) MFC GABA in psychosis, and increased rostral GABA in bipolar disorder (SMD = 0.76, 95% CI = 0.25 to 1.25, p < .01). In depression, reduced rostral MFC GABA (SMD = -0.36, 95% CI = -0.64 to -0.08, p = .01) did not survive correction for multiple comparisons.

ConclusionsThese results substantiate the relevance in the ethology of psychosis spectrum and mood disorders and underline the importance of voxel placement.

labels: psychiatry and clinical psychology


sentences:
The efficacy, effectiveness and safety of SARS-CoV-2 disinfection methods (including ozone machines) in educational settings for children and young people While evidence for the importance of transmission of SARS-CoV-2 from contaminated surfaces is limited, ozone disinfection methods have been considered for surface cleaning as a response to stopping the spread of the virus in educational settings. This rapid evidence summary aimed to search the available literature and summarise findings on the surface survival of SARS-CoV-2, efficacy and effectiveness of ozone machines against SARS-CoV-2, and benefits and harms caused by using these cleaning technologies, including their impact on health. Alternative cleaning technologies, such as light-based technologies and hydrogen peroxide vapour, were also investigated. Findings indicate that gaseous ozone can inactivate different bacteria and viruses, although there is a lack of direct evidence investigating the effect of these cleaning methods on SARS-CoV-2 in real-world settings, specifically in schools. However, regarding harm, ozone is a highly reactive oxidising agent, and high concentrations can contribute to decay of building materials, and health issues (mainly respiratory) by direct exposure or by-product formation. Therefore, leading environmental health organisations do not recommend the use of ozone cleaning technologies in real-world settings, such as schools. Research and policy focus may need to shift towards other interventions that could help reduce transmission, and consequently minimise disruption to education.

Funding statementThe Wales Centre for Evidence Based Care was funded for this work by the Wales Covid-19 Evidence Centre, itself funded by Health & Care Research Wales on behalf of Welsh Government.

TOPLINE SUMMARYO_ST_ABSWhat is a Rapid Evidence Summary?C_ST_ABSThis Rapid Evidence Summary was completed in two weeks to inform policy- decision making. It is based on a systematic search of the literature, conducted in September 2021. Priority is given to studies representing robust evidence synthesis. No quality appraisal or evidence synthesis are conducted, and the summary should be interpreted with caution.

Background / Aim of Rapid Evidence SummarySeveral non-touch disinfectant methods including ozone, light-based technologies, and hydrogen peroxide are being considered to reduce the risk of SARS-CoV-2 virus transmission to children and young people in educational settings. Concerns have been raised about the evidence of efficacy, effectiveness and safety of these technologies in these settings. We aimed to address the following research questions: O_LIWhat is the evidence for the surface survival of SARS-CoV-2?
C_LIO_LIWhat is the evidence for the efficacy (in vitro) and real-life effectiveness (in situ) of ozone machines, light-based technologies and hydrogen peroxide vapour as air or surface disinfectants against SARS-CoV-2?
C_LIO_LIWhat are the potential health effects of ozone, in particular for children and young people and the benefits and harms of using ozone machines?
C_LI

Key FindingsO_ST_ABSExtent of the evidence baseC_ST_ABSA total of 82 tertiary, secondary and primary evidence sources was included

Recency of the evidence baseMost studies were published 2020-21, indirect evidence was included from earlier work from 2006 onwards

Summary of findingsO_LISARS-CoV-2 fragments can be found on surfaces up to seven days later in the community but there is a lack of evidence whether these are viable
C_LIO_LIWhen accounting for both surface survival data and real-world transmission factors, the risk of surface transmission after a person with COVID-19 has been in an indoor space is minor after 72 hours, regardless of last clean
C_LIO_LIThere is evidence from experimental settings that ozone machines, light-based technologies and hydrogen peroxide do inactivate coronaviruses, including SARS-CoV-2
C_LIO_LIThere is a lack of evidence for the effectiveness of ozone machines, light- based technologies and hydrogen peroxide in real-world settings
C_LIO_LIThere are uncertainties about training requirements for staff, methods for assurance of ozone removal and monitoring of occupational exposure
C_LIO_LIThere is strong evidence of a causal relationship between short term ozone exposure and respiratory health issues; these can occur at very low concentrations of ozone; children with asthma are more at risk
C_LIO_LIRooms using ozone machines need to be sealed off to avoid leakage of the ozone gas which is toxic at high concentrations
C_LIO_LIOzone may react with materials in the room to form secondary pollutants (e.g. formaldehyde)
C_LI

The best quality evidenceO_LIThe US EPA 2021 does not recommend ozone for air cleaning and the UK SAGE EMG 2020a does not recommend technologies that "may generate undesirable secondary chemical products that could lead to health effects such as respiratory or skin irritation (medium confidence). These devices are therefore not recommended unless their safety and efficacy can be unequivocally and scientifically demonstrated by relevant test data" (SAGE EMG 2020a).
C_LI

Policy implicationsO_LIThere is no direct evidence for the effectiveness and safety of using ozone machines to deactivate SARS-CoV-2 in real-world educational settings for children, young people and staff
C_LIO_LIThere is evidence for the risk of potential harm to children and young people of ozone machines from either ozone or secondary pollutants, in particular but not only, if used in uncontrolled ways in educational settings
C_LI

Strength of Evidence to dateO_LImoderate evidence for the surface survival of SARS-CoV-2
C_LIO_LIstrong evidence of causal relationship between short term ozone exposure and respiratory health issues
C_LI

labels: public and global health


sentences:
Psychological and financial impacts of COVID-19-related travel measures: An international cross-sectional study BackgroundThe impact of COVID-19 international travel restrictions has to date, not been fully explored, and with the ongoing threat that new variants could potentially restrict movement further, it is important to consider the impacts that travel restrictions have on community members. This study aimed to evaluate the psychological and financial impact of COVID-19 travel restrictions on those separated from their partners or immediate families, as well as temporary visa holders who were unable to migrate.

MethodsBetween 4 November 2021 to 1 December 2021, we executed a cross-sectional online survey targeting three specific groups; (1) those stranded from their partners; (2) those stranded from immediate families; and (3) temporary visa holders unable to migrate or cross international borders. We collected data on respondents demographic profile; the nature of COVID-19-related travel impacts; depression, anxiety, and stress levels (using the validated DASS-21); and finally, data on respondents financial, employment and accommodation situation.

Results1363 respondents located globally completed the survey. 71.2% reported financial stress, 76.8% ([Formula], SD=5.94) reported moderate-to-extremely severe depression, 51.6% ([Formula], SD=5.49) moderate-to-extremely severe anxiety, and 62.6% ([Formula], SD=5.55) moderate-to-extremely severe stress levels. Statistically significant factors associated with moderate-to-extremely severe depression, anxiety, and stress included being female, chronic illness, and experiencing financial stress. Employment during COVID-19 - specifically essential services workers or unemployed - was associated with higher levels of anxiety and stress, with only essential workers being a predictor of higher stress severity. Factors that provided psychological protection included being older and having children.

ConclusionThis study is one of the first to explore the impact COVID-19-related international travel restrictions have had on the financial status and psychological health of affected individuals. It highlights the significant human cost associated with the restrictions and identifies psychologically vulnerable populations. These results will help the design of targeted health and social policy responses.


sentences:
Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature ObjectivesEpigenetic dysregulation plays an important role in the pathogenesis of lupus, a systemic autoimmune disease characterized by autoantibody production. Lupus T cells demonstrate aberrant DNA methylation patterns dominated by hypomethylation of interferon-regulated genes. The objective of this study was to identify additional disease-associated DNA methylation changes in naive CD4+ T cells from an extended cohort of lupus patients and determine the genetic contribution to epigenetic changes characteristic of lupus.

MethodsGenome-wide DNA methylation was assessed in naive CD4+ T cells isolated from a cohort of 74 lupus patients and 74 age-, sex-, and race-matched healthy controls. We applied a trend deviation analysis approach, comparing methylation data in our cohort to methylation data from over 16,500 samples to characterize lupus-associated DNA methylation patterns. Methylation quantitative trait loci (meQTL) analysis was used to determine genetic contribution to lupus-associated DNA methylation changes.

ResultsIn addition to the previously reported epigenetic signature in interferon-regulated genes, we observed hypomethylation of the promoter regions of microRNA (miRNA) genes in the miR-17-92 cluster in lupus patients. Members of this miRNA cluster play an important role in regulating T cell proliferation and differentiation. Expression of two miRNAs within this cluster, miR-19b1 and miR-18a, showed a significant positive correlation with disease activity in lupus patients. meQTL were identified by integrating genome-wide DNA methylation profiles with genotyping data in lupus patients and controls. Patient meQTL show overlap with genetic risk loci for lupus. However, less than 1% of differentially methylated CpG sites in lupus patients were associated with an meQTL, suggesting minimal genetic contribution to lupus-associated epigenotypes.

ConclusionThe lupus defining epigenetic signature, characterized by robust hypomethylation of interferon-regulated genes, does not appear to be determined by genetic factors. Hypomethylation of the miR-17-92 cluster that plays an important role in T cell activation is a novel epigenetic locus for lupus.

labels: rheumatology


sentences: Accuracy of Attestation Among Mohs and Dermatologic Surgery Diplomates Self-regulation is a key tenet of professionalism. We sought to assess the accuracy of self-attestation with respect to the administration of a newly defined field of board sub-specialization. One qualifying pathway to take the written examination for certification in Mohs and Dermatologic Surgery (MDS) is to self-attest to an active practice of Mohs Surgery. Utilizing publicly available data, we find that greater than 6% (111) of new diplomates did not complete an ACGME-approved fellowship or charge CMS in 2019 for greater than one Mohs case per week. In addition, 72 individuals did not complete a fellowship or charge CMS in 2019 for a single Mohs case. This discrepancy between the test qualifications and practice patterns evident from CMS data suggests concern for the reliability of self-regulation in this setting.

labels: medical ethics


sentences:
The application of Raman spectroscopy and chemometric methods for analysis healthy blood and blood with BRCA mutation Presented study included human blood from heathy patients and from patients with BRCA mutation. Raman spectroscopy can be used for BRCA mutation detection and bioanalytical characterization of pathologically changed samples. The aim of this study is to evaluate the Raman biomarkers to distinguish blood samples from healthy patients and from patient with BRCA mutation by Raman spectroscopy. We have proved that Raman spectroscopy is a powerful technique to distinguish between healthy blood and blood with BRCA mutation and to characterize biochemical composition of samples. Partial Least Squares Discriminant Analysis yielded effective and comparable samples classification based on vibrational features. The sensitivity and specificity obtained from PLS-DA have been over 86.5%. The obtained results confirm clinical potential of Raman spectroscopy in oncological diagnostics.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=155 SRC="FIGDIR/small/22271291v1_ufig1.gif" ALT="Figure 1">
View larger version (24K):
org.highwire.dtl.DTLVardef@7a3b7borg.highwire.dtl.DTLVardef@d737aborg.highwire.dtl.DTLVardef@187eb2borg.highwire.dtl.DTLVardef@606f81_HPS_FORMAT_FIGEXP  M_FIG C_FIG

labels: oncology


sentences:
Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy ObjectivesImmunocompromised patients with immune mediated inflammatory diseases (IMIDs), undergoing therapy with B cell depleting agents are among the most vulnerable to experience severe COVID-19 disease as well as respond sub-optimally to SARS CoV-2 vaccines yet little is known about the frequency or severity of breakthrough infection in this population. We have analyzed a large cohort of vaccinated IMIDs patients undergoing B cell depleting therapy for the presence of breakthrough infection and assessed their outcomes.

MethodsUtilizing specific ICD codes the pharmacy records and COVID-19 registry at the Cleveland clinic were used to identify all patients with IMIDS treated with B cell depleting monoclonal antibodies who were vaccinated against SARs CoV-2 and experienced breakthrough infections. Each EMR record was hand-reviewed to extract clinical data including vaccine history, demographics, comorbidities, other therapies, details of B cell depleting therapy, and outcomes. Univariate and multivariable logistic/proportional-odds regression models were used to examine the risk factors for severe outcomes.

ResultsOf 1696 IMIDS patients on B cell depleting therapies 74 developed breakthrough COVID-19. Outcomes were severe with 24 (35%) hospitalized, 11 (15%) patients requiring critical care and 6 (8 %) deaths. Monoclonal antibodies were used on an outpatient basis to treat 21 with only a single patient requiring hospitalization without oxygen support and no deaths.

ConclusionsIn IMIDS patients on B cell depleting therapies breakthrough infections are frequent and associated with severe outcomes. Outpatient use of monoclonal antibody therapy was associated with enhanced clinical outcomes.


sentences: Early emergence phase of SARS-CoV-2 Delta variant in Florida SARS-CoV-2, the causative agent of COVID-19, emerged in late 2020. The highly contagious B.1.617.2 (Delta) Variant of Concern (VOC) was first identified in October 2020 in India and subsequently disseminated worldwide, later becoming the dominant lineage in the U.S. Despite considerable genomic analysis of SARS-CoV-2 in the U.S., several gaps in the understanding of the local dynamics during early introductions remain, which when elucidated could translate the results of viral genomic epidemiology to actionable mitigation efforts. Here, we explore the early emergence of the Delta variant in Florida, U.S. using phylogenetic analysis of representative Florida and globally sampled genomes. We find multiple independent introductions into Florida primarily from North America and Europe, with a minority originating from Asia. These introductions lead to three distinct clades that demonstrated varying relative rates of transmission and possessed five distinct substitutions that were 3-21 times more prevalent in the Florida sample as compared to the global sample. Our results underscore the benefits of routine viral genomic surveillance to monitor epidemic spread and support the need for more comprehensive genomic epidemiology studies of emerging variants. In addition, we provide a model of epidemic spread of newly emerging VOCs that can inform future public health responses.


sentences: SENSOR TECHNOLOGY FOR OPENING NEW PATHWAYS IN DIAGNOSIS AND THERAPEUTICS OF BREAST, LUNG, COLORECTAL AND PROSTATE CANCER This study analyzes the interaction between sensor research and technology and different types of cancer (breast, lung, colorectal and prostate) that generates a high mortality in society with the goals of detecting new directions for improving diagnosis and therapeutics. This study develops an approach of computational scientometrics based on data of the Web of Science from 1991 to 2021 period. The results of this analysis show the vital role of biosensor and electrochemical biosensor applied in breast cancer, lung cancer, and prostate cancer research, except colorectal cancer for latter one. Instead, research of optical sensors is developing mainly in the directions of breast, prostate, and colorectal cancer for improving diagnostics. Finally, oxygen sensor research is developing for breast and lung cancer for applications in breath analysis in new treatment processes. Preliminary results presented here clearly illustrate the evolutionary paths of main sensor technologies that have a great potential in future diagnosis of cancer, but we also need additional examinations of other aspects and factors for supporting appropriate strategies of management of technology to foster the technology transfer of sensor technologies in cancer research for improving diagnosis and, whenever possible, reduce world-wide mortality of cancer ins society.

labels: health informatics


sentences:
Clinical severity of COVID-19 patients admitted to hospitals during the Omicron wave in South Africa BackgroundClinical severity of patients hospitalised with SARS-CoV-2 infection during the Omicron (fourth) wave was assessed and compared to trends in the D614G (first), Beta (second), and Delta (third) waves in South Africa.

MethodsWeekly incidence of 30 laboratory-confirmed SARS-CoV-2 cases/100,000 population defined the start and end of each wave. Hospital admission data were collected through an active national COVID-19-specific surveillance programme. Disease severity was compared across waves by post-imputation random effect multivariable logistic regression models. Severe disease was defined as one or more of acute respiratory distress, supplemental oxygen, mechanical ventilation, intensive-care admission or death.

Results335,219 laboratory-confirmed SARS-CoV-2 admissions were analysed, constituting 10.4% of 3,216,179 cases recorded during the 4 waves. In the Omicron wave, 8.3% of cases were admitted to hospital (52,038/629,617) compared to 12.9% (71,411/553,530) in the D614G, 12.6% (91,843/726,772) in the Beta and 10.0% (131,083/1,306,260) in the Delta waves (p<0.001). During the Omicron wave, 33.6% of admissions experienced severe disease compared to 52.3%, 63.4% and 63.0% in the D614G, Beta and Delta waves (p<0.001). The in-hospital case fatality ratio during the Omicron wave was 10.7%, compared to 21.5%, 28.8% and 26.4% in the D614G, Beta and Delta waves (p<0.001). Compared to the Omicron wave, patients had more severe clinical presentations in the D614G (adjusted odds ratio [aOR] 2.07; 95% confidence interval [CI] 2.01-2.13), Beta (aOR 3.59; CI: 3.49-3.70) and Delta (aOR 3.47: CI: 3.38-3.57) waves.

ConclusionThe trend of increasing cases and admissions across South Africas first three waves shifted in Omicron fourth wave, with a higher and quicker peak but fewer admitted patients, who experienced less clinically severe illness and had a lower case-fatality ratio. Omicron marked a change in the SARS-CoV-2 epidemic curve, clinical profile and deaths in South Africa. Extrapolations to other populations should factor in differing vaccination and prior infection levels.


sentences: Distinct components of cardiovascular health are linked with age-related differences in cognitive abilities Vascular, cardiovascular and neurovascular ageing processes contribute to cognitive impairment. However, the unique and synergistic contributions of cardiovascular factors to cognitive function remain unclear because they are often condensed into a single composite score or examined in isolation of each other. We hypothesized that vascular risk factors, electrocardiographic features and blood pressure indices reveal multiple latent vascular factors, with independent contributions to age differences in cognition. In a population-based deep-phenotyping study of cognition across the lifespan (n=708, age 18-88), path analysis revealed three latent vascular factors dissociating the autonomic nervous system response from two components of blood pressure. These three factors made unique and additive contributions to the variability in crystallized and fluid intelligence. The discrepancy in fluid relative to crystallized intelligence, indicative of cognitive decline, was associated with a latent vascular factor predominantly expressing pulse pressure, suggesting that higher pulse pressure is associated with cognitive decline from expected performance. This association varied with age, such that higher factor scores predicted a greater cognitive discrepancy in older individuals. Controlling pulse pressure may help to preserve cognitive function, particularly in older adults. Our findings highlight the need to better understand the multifactorial nature of vascular aging, its effects on neurocognitive function, and the modifiable risks of cognitive decline.

labels: cardiovascular medicine


sentences: LARisk: An R package for lifetime attributable risk from radiation exposure The lifetime radiation associated risk of cancer incidence has been of interest at least seventy years after atomic bombings of Hiroshima and Nagasaki in 1945. Since most of radiation epidemiological studies are retrospective, it is important to assess the potential magnitude of radiation-related cancer risk. The R-package so-call LARisk implements to easily calculate lifetime attributable risks (LAR) of radiation associated cancer incidence presenting bootstrap-based confidence intervals of the estimated risks. The main characteristics of the LARisk package are to flexibly compute the LAR-associated risks, effectively summarize large data, and promptly update domain-knowledge such as new regression coefficients for excess relative risk or excess absolute risk models, population information, etc. The manuscript provides a complete guide for usage of the LARisk package, which will enable to contribute the prospective studies in radiation epidemiology.


sentences:
Knowledge, Attitude, and Practices of Health Professionals Working in A Major Health Care System Regarding Social Determinants of Health (SDOH) and Community Health Workers (CHWs) IntroductionSocial Determinants of Health (SDOH) play a key role in impacting the health outcomes of any population. Community Health Workers (CHWs) play an important role in health promotion, disease prevention, and management of chronic illnesses. This study aims at exploring the knowledge, attitude, and practices of health care professionals towards CHWs to fully integrate in them for mitigation of SDOH.

Materials and MethodsA cross-sectional study utilizing an anonymous survey questionnaire across 4 clinical sites was carried out from June 2016 to November 2017 in a major healthcare system (Presbyterian) in Albuquerque, New Mexico. Descriptive statistics (means, standard deviations, and proportions) were collected. Categorical variables were analyzed using Chi-squared and Fishers exact test; a p-value of <0.05 was considered statistically significant, using SAS 9.4 statistical software.

ResultsAlmost half of the health professionals had no knowledge about the social determinants of health. Almost a quarter of the health professionals did not know the role of CHWs in healthcare, however, 100% of the respondents across all clinic and practice locations and regardless of their role or scope of the practice believed that greater involvement of CHWs would improve patient outcomes.

ConclusionThere is a knowledge deficit among health care providers about the social determinants of health (SDOH).More educational and teaching opportunities on SDOH and CHWs to all health professionals should be provided to all health professionals so the clinical team can help manage SDOH in addition to providing clinical care.

labels: primary care research


sentences: Accurate non-invasive mass and temperature quantifications with spectral CT Spectral CT has been increasingly implemented clinically for its better characterization and quantification of materials through its multi-energy results. It also facilitates calculation of physical density utilizing the Alvarez-Macovski model without approximations. These spectral physical density quantifications allow for non-invasive mass measurements and temperature evaluations by manipulating the definition of physical density and thermal volumetric expansion, respectively. To develop the model, original and parametrized versions of the Alvarez-Macovski model and electron density-physical density model were validated with a phantom. The best physical density model was then implemented on clinical spectral CT scans of ex vivo bovine muscle to determine the accuracy and effect of acquisition parameters on mass measurements. In addition, the relationship between physical density and changes in temperature was evaluated by scanning and subjecting the tissue to a range of temperatures. A linear fit utilizing the thermal volumetric expansion was performed to assess the correlation. The parametrized Alvarez-Macovski model performed best in both model development and validation with errors within {+/-}0.02 g/mL. As observed with muscle, physical density was not significantly affected by dose and acquisition mode but was slightly affected by collimation. These effects were also reflected in mass measurements, which demonstrated accuracy with a maximum percent error of 0.34%, further validating the physical density model. Furthermore, physical density was strongly correlated (R of 0.9781) to temperature changes through thermal volumetric expansion. Accurate and precise spectral physical density quantifications enable non-invasive mass measurements for pathological detection and temperature evaluation for thermal therapy monitoring in interventional oncology.

labels: radiology and imaging


sentences:
Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic BackgroundCancer and systemic anti-cancer treatment (SACT) have been identified as possible risk factors for infection and related severe illness associated with SARS-CoV-2 virus as a consequence of immune suppression. The Scottish COVID CAncer iMmunity Prevalence (SCCAMP) study aims to characterise the incidence and outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment during the COVID-19 pandemic and their antibody response following vaccination.

Patients and MethodsEligible patients were those attending secondary care for active anti-cancer treatment for a solid tumour. Blood samples were taken for total SARS-CoV-2 antibody assay (Siemens) at baseline and after 1.5, 3, 6 and 12 months. Data on COVID-19 infection, vaccination, cancer type, treatment and outcome was obtained from routine electronic health records.

ResultsThe study recruited 766 eligible participants between 28th May 2020 and 31st October 2021. The median age was 62.7 years, and 66.5% were female. Most received cytotoxic chemotherapy (79%), with the remaining 14% receiving immunotherapy and 7% receiving another form of anti-cancer therapy (radiotherapy, other systemic anti-cancer treatment). 48 (6.3%) tested positive for SARS-CoV-2 by PCR during the study period. The overall infection rate matched that of the age-matched local general population until May 2021, after which population levels appeared higher. Antibody testing detected additional evidence of infection prior to vaccination, taking the total number to 58 (7.6%). There was no significant difference in SARS-CoV-2 PCR positive test rates based on type of anti-cancer treatment. Mortality proportion was similar between those who died within 90 days of a positive SARS-CoV-2 PCR and those with no positive PCR (10.4% vs 10.6%). Death from all causes was lowest among vaccinated patients, and of the patients who had a positive SARS-CoV-2 PCR at any time, all of those who died during the study period were unvaccinated. Multivariate analysis correcting for age, gender, socioeconomic status, comorbidities and number of previous medications revealed that vaccination was associated with a significantly lower infection rate regardless of treatment with chemotherapy or immunotherapy with hazard ratios of 0.307 (95% CI 0.144-0.6548) or 0.314 (95% CI 0.041-2.367) in vaccinated patients respectively. Where antibody data was available, 96.3% of patients successfully raised SARS-CoV-2 antibodies at a time point after vaccination. This was unaffected by treatment type.

ConclusionSCCAMP provides real-world evidence that patients with cancer undergoing SACT have a high antibody response and protection from SARS-CoV-2 infection following COVID-19 vaccination.

Highlights- The SCCAMP dataset represents the largest longitudinal study of patients with cancer undergoing anti-cancer treatment during the COVID-19 pandemic
- Rates of infection in the cancer cohort mirrored those of the local age adjusted population
- Vaccination was effective in patients with cancer undergoing active treatment in terms of antibody response and SARS-CoV-2 PCR rates
- Treatment type did not impact the rate of SARS-CoV-2 antibody response


sentences:
Tinnitus Subtyping with Subgrouping Within Group Iterative Multiple Model Estimation: An Ecological Momentary Assessment Study BackgroundTinnitus is a heterogeneous condition associated with moderate to severe disability, but the reasons why only a subset of individuals is burdened by the condition are not fully clear. Ecological momentary assessment (EMA) allows a better understanding of tinnitus by allowing individualized models and by capturing the fluctuations of tinnitus symptoms and other behavioral dynamics as they occur, and therefore minimizing the risk of recollection bias. The TrackYourTinnitus (TYT) mobile app provides a platform for collecting ecologically valid time series data from tinnitus users and can be used to address questions like how mood, concentration, tinnitus distress, or loudness relate over time. Whether any of those variables have an influence over the next day, that is, whether any of these variables are auto- or cross-correlated, is still unanswered.

ObjectivesAssess whether behavioral and symptom-related data from tinnitus users from the TYT app auto- and cross-correlate in different time lags, both within and between individuals.

MethodsAnonymized data was collected from 278 users of the iOS or Android TYT apps between 2014 and 2020. Tinnitus-related distress, tinnitus loudness, concentration level, overall mood, emotional arousal, and overall stress level were assessed using a 10-point visual analog scale via a daily survey. Auto- and cross-correlations were calculated for participants who used the app for at least 10 consecutive days. Lagged cross-correlation was used to investigate the dynamics of each of these variables over time at the group level, followed by linear regression with elastic net regularization for each user. Additionally, subgrouping within group iterative multiple model estimation (S-GIMME) was used to model the behavioral dynamics at the group, subgroup, and individual levels with data collected from 32 users.

ResultsNo autocorrelation or cross-correlation was observed at the group level between the variables assessed. However, application of the regression models with elastic net regularization identified individualized predictors of tinnitus loudness and distress for most participants, with the models including contemporaneous and lagged information from the previous day. The finding that a subset of users experienced lagged and contemporaneous dynamics was corroborated by the models from S-GIMME. The models had adequate fits, with both contemporaneous and lagged coefficients obtained for most individuals. Two subgroups were identified, the first consisting of users where both contemporaneous and lagged effects were observed, and a second subgroup consisting of users whose dynamics were mainly of contemporaneous effects.

DiscussionWe showed that tinnitus loudness and tinnitus distress are affected by the contemporaneous and lagged dynamics of behavioral and emotional processes measured through EMA. These effects were seen at the group, subgroup, and individual levels. The relevance EMA and the implications of the insights derived from it for tinnitus care are discussed, especially considering current trends towards the individualization of tinnitus care.


sentences:
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study IntroductionSARS-CoV-2 vaccination has been effective in protecting against severe COVID-19 infections and related mortality. It is recommended for all individuals including patients with inflammatory bowel disease (IBD). However, safety data is lacking in this group of patients. Therefore, we aim to evaluate the short- and long-term vaccine related adverse events (AEs) in patients with IBD.

MethodThis is a prospective, observational cohort study investigating short- and long-term AEs related to BNT162b2 vaccine in patients with IBD (study group) after first and second dose compared to healthy participants (study group). Patients were recruited at the time of attendance to clinic or infusion rooms. Short term (<3 weeks) localized and systemic AEs were assessed via questionnaire. Follow-up phone-based survey was made to collect data on long term (up to 24 weeks) AEs.

ResultsA total of 408 patients answered the questionnaires, 204 patients in each group, the study and control group. No serious adverse events were reported in either the study nor the control group after the first or the second dose. Participants in the control group reported more frequent pain at the injection site than those in the study group after the first dose (58 (57%) vs 38 (37%) respectively, P-value= 0.005). After the second dose, tiredness was reported more frequently in the control group [49 (48%)] compared to the study group [25 (24%), (P-value<0.001)]. At 20-24 weeks post vaccination, 386 out of 408 (94.6%) patients were willing to participate in the follow-up phone based questionnaire (196 (96.1%) in the study group vs 190 (93.1%) in the control group). In both groups, none of the patients reported local, systemic or severe adverse events (0 out of 386) at week 20-244 post second dose.

ConclusionThe BNT162b2 vaccine is safe in patients with IBD. No severe or long-term adverse events were reported in our study. The frequency of local and systemic adverse events after the second dose was generally higher among healthy participants compared to patients with IBD. Further studies including a larger cohort with longer follow-up duration are needed to assess for possible rare adverse events.

labels: gastroenterology


sentences:
Pan-cancer analyses reveal genomics and clinical characteristics of the down regulated genes for recurrent myocardial infarction in cancer BackgrounEarly identification of the occurrence and progression of coronary ischemic events is particularly important for the diagnosis and treatment of coronary heart disease complicated with tumor. Therefore, it is of great significance to analyze biomarkers and regulatory factors of recurrent myocardial infarction after first myocardial infarction.In order to specify the regulatory factor of coronary heart disease or myocardial infarction on tumor occurrence and metastasis and clinical survival effect, we select from GEO database for the first time of recurrence after myocardial infarction, myocardial infarction, microarray data set, the comprehensive evaluation of the data set is the key cut genes and cancer, tumor prognosis, the tumor extends into the immune level of mutation, etc.The purpose of this study is to discover the role of myocardial infarction regulatory factors in cancer.

MethodsGSE48060 chip data set was downloaded from GEO database to obtain gene expression profiles of blood samples from normal cardiac function control and first AMI patients within 48 hours after the first myocardial infarction.GEO2R online tool and Excel software were used to screen the differential genes between the reinfarction samples and the normal samples in the GSE48060 chip data set.DAVID database was used for enrichment analysis of GO and KEGG of DEGs.The PPI network was constructed and visualized by Using The STRING database and Cytoscape software, and the key genes were screened by the CytoHubba plug-in of Cytoscape software.TIMER database and GEPIA2 website were used to analyze and verify the expression levels of key genes between tumor tissues and normal tissues in generalized carcinoma.GEPIA2 website was used to analyze the correlation between key genes and tumor prognosis.The correlation between key gene expression and tumor purity and each immune cell was analyzed by TIMER database.CBioPortal website was used to analyze the mutation and correlation of key genes in tumors.

ResultsThrough analysis, the difference genes of 17 GSE48060 chip data sets of reinfarction samples and normal samples were obtained, and the above genes were all down-regulated genes.Five key genes were obtained through constructing PPI network, which were GART, SOD2, KLRF1, ERAP2 and CXCL5.According to the TIMER result, The expression level of GART in BLCA, BRCA, CHOL, COAD, ESCA, HNSC, KICH, KIRC, LIHC, LUAD, LUSC, PRAD, READ, STAD and THCA was significantly different from that in normal tissues (P < 0.001).The expression levels of SOD2 in BRCA, ESCA, KICH, KIRC, KIRP, LUSC, SKCM and STAD were significantly different from normal tissues (P < 0.001).The expression levels of KLRF1 in BRCA, COAD, HNSC, LIHC, LUAD, LUSC, PRAD, READ, STAD and UCEC were significantly different from those in normal tissues (P < 0.001).The expression levels of ERAP2 in BRCA, KIRC and LUSC were significantly different from those in normal tissues (P < 0.001).The expression levels of CXCL5 in BRCA, COAD, ESCA, HNSC, KICH, KIRC, KIRP, LUAD, LUSC, PRAD, STAD, THCA and UCEC were significantly different from those in normal tissues (P < 0.001).The results of GEPIA2 showed that the expression levels of GART in CESC, CHOL, ESCA, KICH, LUSC, SARC and STAD showed significant differences between tumor tissues and normal tissues (P < 0.05).There were significant differences in the expression levels of SOD2 in BLCA, BRCA, ESCA, PAAD and PCPG between tumor tissues and normal tissues (P < 0.05), and there were significant differences in the expression levels of KLRF1 in LUAD and LUSC between tumor tissues and normal tissues (P < 0.05).There were significant differences in ERAP2 expression between tumor tissues and normal tissues in KICH and LUSC (P < 0.05), and there were significant differences in CXCL5 expression between tumor tissues and normal tissues in CHOL, COAD, ESCA, LUAD, LUSC, READ and STAD (P < 0.05).The results of tumor survival analysis indicated that the correlation between the overall tumor survival (OS) of GART and CESC, KIRC, LUAD, READ and SARC was statistically significant (P < 0.05).The correlation between SOD2 and TUMOR OS of SKCM was statistically significant (P < 0.05).The correlation of TUMOR OS between KLRF1 and HNSC was statistically significant (P < 0.05).The correlation between CXCL5 and TUMOR OS of KICH and KIRC was statistically significant (P < 0.05).There was statistically significant correlation between GART and LUADs tumor stage (P < 0.05), SOD2 and SKCMs tumor stage (P < 0.05), CXCL5 and KICH and KIRCs tumor stage (P < 0.05).The GART gene expression level is significantly correlated with various immune cells in CESC, KIRC, LUAD, READ and SARC.The expression level of SOD2 gene was significantly correlated with various immune cells in SKCM.The expression level of KLRF1 gene was significantly correlated with various immune cells in HNSC.The expression level of CXCL5 gene was significantly correlated with various immune cells in KICH and KIRC.The proportion of mutations in COAD, KICH, LIHC, READ, SKCM and THCA was the highest, the proportion of amplification in BRCA, ESCA, HNSC, KIRC, LUSC and STAD was the highest, and the proportion of severe deletion in LUAD and PRAD was the highest.

ConclusionThe key down-regulated genes of recurrent myocardial infarction after initial myocardial infarction are related to tumor genesis, metastasis, clinical survival and immune invasion.Key down-regulated genes in recurrent myocardial infarction may serve as important biomarkers for the diagnosis and treatment of cancer.

labels: genetic and genomic medicine


sentences:
Application of the Weight Self-Stigma Questionnaire (WSSQ) in Subjects with Overweight and Obesity living in Italy AimsAlthough weight-based stigmatization is widespread in everyday life, a suitable measure of weight self-stigma is currently unavailable for those with overweight/obesity whose primary language is Italian. The purpose of this study was to translate and test the psychometric properties of the Italian version of the Weight Self-stigma Questionnaire (I-WSSQ) to administer it to adults with overweight/obesity.

Materials and MethodsA cross-sectional study was conducted on 214 adults with overweight or obesity. Data including Body Mass Index (BMI), I-WSSQ, and Body Uneasiness Test (BUT) scores were collected from April the 2nd to July the 6th, 2021.

ResultsReliability was assessed through internal consistency: the Cronbach  of the I-WSSQ was  =.814, indicating good reliability. The exploratory factor analysis revealed a two-factor structure of I-WSSQ (self-devaluation and fear of enacted stigma, respectively) that explained 49,25% of the total variance. In addition, the I-WSSQ score directly correlated with BMI and BUT score, indicating an acceptable criterion-related validity.

ConclusionThe I-WSSQ shows adequate reliability and validity. Health professionals may use the I-WSSQ to assess the weight self-stigma of adults with overweight/obesity whose primary language is Italian.


sentences:
Breast and colorectal cancer awareness in Malaysians and barriers towards screening: A systematic review BackgroundBreast cancer (BC) and colorectal cancer (CRC) are considered primary cancers that affect both male and females globally. In Malaysia, BC is the most commonly diagnosed cancer among women of all ethnic groups and CRC is the second most common cancer in males and the second most common cancer in females. This systematic review was carried out to assess cancer symptom awareness and barriers to undergoing cancer screening for BC and CRC.

MethodsA pre-defined search was conducted between January 2008 and December 2018 using the following databases: MEDLINE, Embase, CINAHL, Web of Science, PsycINFO, Scopus and Cochrane Library for relevant articles. The search was updated in June 2020. Reviewers independently performed the data extraction and quality assessment of the included study according to the Joanna Briggs Institute assessment tools.

Result22 studies met the inclusion criteria (BC n=11; CRC n=11). Nine studies assessed symptom knowledge for BC and eight for CRC. Two studies described barriers towards cancer screening for BC and one for CRC. Four CRC studies assessed symptoms knowledge and cancer screening barriers. The most commonly reported BC symptoms were  painless breast lump(27.6% - 90.8%),  nipple discharge (1.6% - 74.5%) and  pain in breast/ breast region (11.5% - 82.8%) meanwhile CRC symptoms were  change in bowel habits (new-onset diarrhoea or constipation) (28.4% - 86.6%),  bleeding and/or bleeding from the back passage (11.5% - 71.9%) and  weight loss (9.3% - 83.4%).  Financial issue (10% - 17.5%) was the most frequent blockade identified towards BC screening meanwhile  fear of result (27.6% - 32.1%) for CRC screening by Malaysians. Overall the studies carried out in Malaysia, six studies on BC symptom knowledge and one study on BC screening barrier were scored as medium study quality while four studies on CRC symptom knowledge and three studies on CRC screening barriers were scored as medium study quality.

ConclusionStudies described varied and overall, limited, symptom awareness and barriers towards BC and CRC screening which likely contributes to the delayed presentation of cancers in Malaysia. There is a need for improving the awareness of BC and CRC symptoms as well as the importance of screening to encourage the early presentation of symptomatic cancer patients and down-staging of cancer.


sentences:
Using a transection paradigm to enhance the repair mechanisms of an investigational human cell therapy One promising strategy in cell therapies for Parkinsons Disease (PD) is to harness a patients own cells to provide neuroprotection in areas of the brain affected by neurodegeneration. No treatment exists to replace cells in the brain. Thus, our goal has been to support sick neurons and slow neurodegeneration by transplanting living repair tissue from the peripheral nervous system into the substantia nigra of those with PD. Our group has pioneered the transplantation of transection-activated sural nerve fascicles into the brain of human subjects with PD. Our experience in sural nerve transplantation through FDA-regulated clinical trials has supported the safety and feasibility of this approach. We are among the first to collect human sural nerve both before and after transection and to perform single nuclei RNA sequencing to determine the cell types present. We collected nerve tissue before and approximately 2 weeks after sural nerve transection for immunoassays from 15 participants, and collected from two additional participants for single nuclei RNA sequencing. We quantified the expression of key neuroprotective and anti-apoptotic genes along with their corresponding protein levels using immunoassays. The single nuclei data clustered into 10 distinctive groups defined on the basis of previously published cell type-specific genes. Transection-induced reparative peripheral nerve tissue showed RNA expression of neuroprotective factors and anti-apoptotic factors across multiple cell types after nerve injury induction. Key proteins of interest (BDNF, GDNF, beta-NGF, PDGFB, and VEGF) were significantly upregulated in reparative tissue compared to naive. These results provide insight on this repair tissues utility as a neuroprotective cell therapy.

Clinical TrialClinicaltrials.gov (Trial registration number NCT02369003)

https://clinicaltrials.gov/ct2/show/NCT02369003).

labels: neurology


sentences: Spillover Benefit of Pre-Exposure Prophylaxis for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model We developed an agent-based model using a trial emulation approach to quantify effect measure modification of key variables on spillover effects of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Atlanta, GA. PrEP may impact not only the individual prescribed, but also their partners and beyond, known as spillover. We simulated a two-stage randomized trial with eligible components ([≥]3 agents and [≥]1 HIV+ agent) first randomized to intervention or control (no PrEP). Within intervention components, agents were randomized to PrEP with intervention coverage of 70%, providing insight into a high PrEP coverage strategy. We evaluated effect modification by component level characteristics and estimated spillover effects using an extension of randomization-based estimators. We observed an attenuation of the spillover effect when agents were in components with a higher prevalence of either drug use or bridging potential (if an agent acts as a mediator between [≥]2 connected groups of agents). The estimated spillover effects were larger in magnitude among components with either higher HIV prevalence or greater density (number of existing compared to all possible partnerships). Consideration of effect modification is important when evaluating the spillover of PrEP among MSM.

labels: hiv aids


sentences: Favourable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies Patients undergoing immune-modifying therapies demonstrate a reduced humoral response after COVID-19 vaccination, but we lack a proper evaluation of the impact of such therapies on vaccine-induced T cell responses. Here, we longitudinally characterised humoral and Spike-specific T cell responses in inflammatory bowel disease (IBD) patients who are on antimetabolite therapy (azathioprine or methotrexate), TNF inhibitors and/or other biologic treatment (anti-integrin or anti-p40) after mRNA vaccination up to 3 months after completing two vaccine doses. We demonstrated that a Spike-specific T cell response is not only induced in treated IBD patients at levels similar to healthy individuals, but also sustained at higher magnitude, particularly in those treated with TNF inhibitor therapy. Furthermore, the Spike-specific T cell response in these patients is mainly preserved against mutations present in SARS-CoV-2 B.1.1.529 (Omicron) and characterized by a Th1/IL-10 cytokine profile. Thus, despite the humoral response defects, the favourable profile of vaccine-induced T cell responses might still provide a layer of COVID-19 protection to patients under immune-modifying therapies.


sentences:
Single Injection Nerve Blocks Plus IV Lidocaine Infusions as an Alternative to Continuous Nerve Blocks for Perioperative Pain Management: A retrospective review. PurposeContinuous nerve blocks (CNBs) and intravenous lidocaine infusions (IV Lido) represent an effective approach to perioperative pain management. We hypothesized that a single injection nerve block (SNB) plus intravenous lidocaine infusion (IV Lido) would be as effective as CNBs. Furthermore, since recently, the use of facial plane blocks are increasingly advocated, we compared CNBs vs SNBs plus IV Lido in patients undergoing erector spinae plane (ESP) and quadratus lumborum (QL) blocks for video assisted thoracic surgery (VATS) and abdominal/retroperitoneal surgeries, respectively.

Patients and MethodUsing our IRB approved registry (PRO10120146), we retrospectively reviewed the electronic record of 105 patients, including 51 patients who underwent VATS and received either single injection erector plane block (SESPB) plus IV lido or continuous erector spinae plane block (CESPB), and 54 patients who underwent major abdominal surgery and received either single injection quadratus lumborum block (SQLB) plus IV Lido or continuous quadratus lumborum block (CQLB). Demographics, verbal pain scores (0-10), and opioid consumption (morphine intravenous equivalent; MIVE), all in the context of the same multimodal approach (acetaminophen, ketamine, dexmedetomidine, and ketorolac) were collected at 24, 48, and 72 hours after surgery. Alpha was set to 0.05.

ResultsSNBs plus IV Lido were as effective as CNBs regarding pain control and total MIVE at 24, 48, or 72 hours after surgery. Subgroup analysis indicated similar findings were observed in patients who underwent VATS or major abdominal surgery.

ConclusionsThis analysis suggests that SNBs plus IV Lido are as effective as CNBs for perioperative pain management when ESP or QL blocks are used for VATS or major abdominal surgery, respectively.

labels: anesthesia


sentences: Multi-ancestry Genome-wide Association Study of Varicose Veins Reveals Polygenic Architecture, Genetic Overlap with Arterial and Venous Disease, and Novel Therapeutic Opportunities BackgroundVaricose veins represent a common cause of cardiovascular morbidity, with limited available medical therapies. Although varicose veins are heritable and epidemiologic studies have identified several candidate varicose veins risk factors, the molecular and genetic basis remains uncertain. Here, we analyzed the contribution of common genetic variants to varicose veins using data from the VA Million Veteran Program and other large multi-ancestry biobanks. Among 49,765 individuals with varicose veins and 1,334,301 disease-free controls, we identified 139 risk loci. We identified genetic overlap between varicose veins, other vascular diseases, and dozens of anthropometric factors. Using Mendelian randomization, we prioritized novel therapeutic targets via integration of proteomic and transcriptomic data. Finally, topological enrichment analyses confirmed the biologic roles of endothelial shear flow disruption, inflammation, vascular remodeling, and angiogenesis. These findings may facilitate future efforts to develop non-surgical therapies for varicose veins.


sentences:
An Analysis Between Trump's Presidency and Health-Seeking Behaviors of African Americans in the United States BackgroundSlavery legally ended over 150 years ago, yet African Americans are still oppressed. The lingering effects of systemic and institutional racism are still present in all walks of life, especially in healthcare. As a result, Black patients have historically been less likely to seek preventative care and subsequently, reported lower health outcomes compared to their white counterparts. The election of Donald Trump in 2016 forced a shift in that narrative. This study aimed to investigate whether there was any correlation between changing racial preferences fueled by Trumps racist rhetoric and the health-seeking behaviors of Black patients. Through this, we explored if the number of Black patients that reported not having a primary care physician has changed, and how online search history trends researching Black physicians have also changed.

MethodsThis study utilized datasets from the Behavioral Risk Factor Surveillance System (BRFSS) and Google Trends. Pearsons correlation testing was run to establish any correlation between the number of google searches and positive health-seeking behaviors.

ResultsGoogleTrends data does support an increased popularity for the search term "black doctor near me" over the years of 2015-2018, supporting our hypothesis. Multiple logistic regression analysis was performed to determine if race, among other variables, was a significant predictor for our predetermined health indicators. The results showed race was significant in nine out of our eleven health indicators.

DiscussionDespite decades of work to minimize healthcare disparities, this study has demonstrated how much more still needs to be done. It has shown how the intersection of seemingly unrelated issues, such as politics and health, as described in this study, can drastically impact health outcomes. This study highlights the importance of targeted and equitable programming to ensure quality care for all, that can withstand political and social pressures.


sentences:
Cell-Mediated Immune Response after COVID 19 Vaccination in Patients with Inflammatory Bowel Disease IntroductionMost patients with IBD mount an antibody response to mRNA COVID-19 vaccines, but few studies have evaluated the cell mediated immune response (CMIR).

MethodsWe performed a prospective study (HERCULES) to evaluate CMIR among patients with IBD and healthy controls (HC) after completion of the primary series of mRNA COVID-19 vaccines.

ResultsOne hundred 158 patients with IBD and 20 HC were enrolled. The majority (89%) of IBD patients developed a CMIR which was not different than HC (94%, p=0.6667). There was no significant difference (p=0.5488) in CMIR response between those not immunosuppressed (median 255 Spike T cells/million PBMC, IQR 146, 958) and immunosuppressed (median 377, IQR 123, 1440). There was also no correlation between antibody responses and CMIR (p=0.5215)

DiscussionMost patients with IBD achieved CMIR to a COVID-19 vaccine. Future studies are needed evaluating sustained CMIR and clinical outcomes.


sentences: Cannabis Smoking and Academic Achievement in Colombian High-School Students A cross-sectional study was designed with high-school students. The studys objective was to establish the relationship between cannabis smoking and academic achievement, adjusted for clinically important depressive symptoms and family dysfunction. The authors quantified lifetime cannabis smoking, perception of academic achievement, clinically important depressive symptoms, and family dysfunction. It was computed crude association between cannabis smoking and academic achievement and adjusted by clinically important depressive symptoms and family dysfunction. A total of 1,462 students between 13 and 17 years participated in the research; 11.63% reported lifetime cannabis smoking; 30.78%, poor-fair academic achievement; 7.05%, clinically important depressive symptoms; and 76.06%, family dysfunction. The lifetime cannabis smoking was significantly associated with poor-fair academic achievement after adjusting for clinically important depressive symptoms and family dysfunction (OR = 1.61, 95%CI 1.16 - 2.24). In conclusion, lifetime cannabis smoking is related to poor-fair academic achievement among high-school students in Santa Marta, Colombia.


sentences: Cerebral Organoids Containing an AUTS2 Missense Variant Model Microcephaly Variants in the AUTS2 gene are associated with a broad spectrum of neurological conditions characterized by intellectual disability, microcephaly, and congenital brain malformations. Here, we use a human cerebral organoid (CO) model to investigate the pathophysiology of a heterozygous de novo missense AUTS2 variant identified in a patient with multiple neurological impairments including primary microcephaly and profound intellectual disability. Proband COs exhibit reduced growth, deficits in neural progenitor cell (NPC) proliferation and disrupted NPC polarity within ventricular zone-like regions compared to control COs. We used CRISPR-Cas9-mediated gene editing to correct this variant and demonstrate rescue of impaired organoid growth and NPC proliferative deficits. Single-cell RNA sequencing revealed a marked reduction of G1/S transition gene expression and alterations in WNT-{beta}-Catenin signaling within proband NPCs, uncovering a novel role for AUTS2 in NPCs during human cortical development. Collectively, these results underscore the value of COs to uncover molecular mechanisms underlying AUTS2 syndrome.


sentences:
The effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate-cancer care ObjectivesTo investigate the impact on efficiency and quality of pre-prostatectomy multidisciplinary therapy conferences (MDT) at Karolinska University Hospital related to the use of a digital solution compared to standard of care. Further, to explore whether gains in MDT efficiency and quality impact oncological or functional patient outcomes.

MethodsWe conducted a prospective, observational study of preoperative prostate-cancer MDT at Karolinska between February 2017 and March 2021. We compared efficiency and quality of the standard MDT and the MDT using the digital solution IntelliSpace Precision Medicine Multidisciplinary Team Orchestrator (ISPM) based on the previously used MDT-MODe approach. Clinical and patient-reported functional outcomes were derived from the medical records and the Swedish National Prostate Cancer Register (NPCR).

ResultsWhile ISPM was used during the multidisciplinary therapy conference, the time spent per patient was reduced by 24 % (p<0.001) and most of the MDT-MODe items were scored significantly higher. There was a reduction in pelvic lymph-node dissection procedures in the ISPM cohort (p=0.001) and an increased proportion of unilateral nerve-sparing procedures (p=0.005), while all other outcome-related measures were not significantly different between the two patient groups.

Discussion & ConclusionTo increase the value of the MDT, all data relevant for treatment decision need to be purposefully presented and compiled, which also enables secondary use of the data.

The use of a digital solution during preoperative MDTs for prostate-cancer decision-making at Karolinska University Hospital improved the efficiency and quality of this multidisciplinary team meeting without impacting patient outcomes.

What is already known?O_LIMultidisciplinary therapy conferences are widely used in modern cancer care.
C_LIO_LIPatients discussed in a multidisciplinary therapy conference are more likely to receive appropriate staging and treatment.
C_LIO_LIThe multidisciplinary therapy conference is time consuming and rarely digitalized or adequately structured.
C_LI

What does this paper add?O_LIThe use of a digital clinical decision support system during preoperative prostate-cancer multidisciplinary therapy conferences improved the efficiency and quality of the meetings.
C_LIO_LIThe introduction of this digital clinical decision support system was not associated with changes in oncological and functional outcomes after surgery.
C_LI

labels: health systems and quality improvement


sentences: Immunological pathways underlying autism: Findings from Mendelian randomization and genetic colocalisation analyses. Emerging evidence implicates the role of inflammation and immunity in autism. However, little is known about the involvement of specific immunological pathways and their causal role. In 18,381 autism cases and 27,969 controls from the PGC and the iPSYCH consortia, we investigated whether 15 cytokines implicated in the differentiation and function of CD4+ T cell subsets (TH1, TH2, TH9, TFH, TH17, TReg) could be causally linked to autism. Within a Mendelian randomization framework, we used protein quantitative trait loci (pQTLs; N=1,000-3,394) to assess the effects of genetically proxied levels of plasma cytokines on autism. We additionally used brain cortex expression quantitative trait loci (eQTLs; N= 6,601) to investigate whether genetically predicted expression of the genes encoding the cytokines of interest influence autism. We performed colocalisation to assess the possibility that the identified effects were confounded due to Linkage Disequilibrium (LD). We also assessed the possibility of reverse causation. We report consistent evidence for causal effects of genetically predicted levels of IFN-{gamma}R1, IL-12R{beta}1 (TH1), and IL-4RA, IL-5RA, IL-13RA1 (TH2) on autism. We identified brain-specific effects of genetically predicted expression of IFNGR1, IL12RB1, IL23A, which in the case of IFNGR1 and IL23A were additionally supported by evidence suggestive of colocalisation. Findings appeared unlikely to be influenced by reverse causation. Our findings are consistent with a potentially causal effect of TH1 and TH2 pathway cytokines in autism, and further research is required to elucidate the pathways via which TH1 and TH2 influence its phenotypic presentation.


sentences:
Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy BackgroundClinically relevant genetic predictors of radiation response for cervical cancer are understudied due to the morbidity of repeat invasive biopsies required to obtain genetic material. Thus, we aimed to develop a novel noninvasive cervical swab technique to collect tumor DNA with adequate throughput to perform whole-exome sequencing (WES) at serial time points over the course of chemoradiation therapy (CRT).

MethodsCervical cancer tumor samples from patients undergoing chemoradiation were collected at baseline, at week 1, week 3, and at the completion of CRT (week 5) using a noninvasive swab-based biopsy technique. Swab samples were analyzed with whole-exome sequencing (WES) with mutation calling using a custom pipeline optimized for shallow whole-exome sequencing with low tumor purity. Tumor mutation changes over the course of treatment were profiled.

Results217 samples were collected and successfully sequenced for 70 patients. A total of 33 patients had a complete set of samples at all four time points. The mean mapping rate was 98% for all samples, and the mean target coverage was 180. Overall mutation frequency decreased during CRT with disease response but mapping rate and mean target coverage remained at >98% and >180 reads at week 5.

ConclusionThis study demonstrates the feasibility and application of a noninvasive swab-based technique for WES analysis to investigate dynamic tumor mutational changes during treatment and may be a valuable approach to identify novel genes which confer radiation resistance.


sentences: Polygenic scores in disease prediction: evaluation using the relevant performance metrics We examine the performance of polygenic scores in screening and disease prediction using metrics which are firmly established for non-genetic tests but rarely reported in evaluations of polygenic scores. Using performance metrics in the Polygenic Score Catalog (odds and hazard ratios, area under the receiver operating characteristic curve or C-index), we calculate the sensitivity or detection rate (DR5) for polygenic score cut-offs that define a 5% false positive rate (FPR). To examine clinical and public health relevance, we use information on disease incidence to calculate the odds of being affected given a positive result (OAPR; the ratio of true to false positives) both for an individual and a population. Polygenic scores typically detect 7.6 - 16.4% (and therefore miss 83.6 - 92.4%) of affected individuals with a 5% FPR. For a polygenic score for coronary artery disease (CAD) with a DR5 of 12% (88% of cases missed), the OAPR is 1: 3.75 if used in a population with an average 10-year CAD risk of 10%, and 1: 41 in a population with an average 10-year CAD risk of 1%. For a polygenic score for breast cancer also with a DR5 of 12% and a population average 10-year risk of 1 in 65 (odds =1: 64), odds are reduced to 1: 91 for a woman with a polygenic score at the 25th centile and increased to 1: 53 for a woman with a result at the 75th centile. Analysis using the relevant metrics reveals the weak predictive performance of polygenic risk scores, which limits their effectiveness in screening and disease prevention.


sentences:
Longitudinal Trend Monitoring of Multiple Sclerosis Ambulation using Smartphones AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSGoalC_ST_ABSSmartphone and wearable devices may act as powerful tools to remotely monitor physical function in people with neurodegenerative and autoimmune diseases from out-of-clinic environments. Detection of progression onset or worsening of symptoms is especially important in people living with multiple sclerosis (PwMS) in order to enable optimally adapted therapeutic strategies. MS is a disease whose symptoms typically follow subtle and fluctuating disease courses, patient-to-patient, and over time. Current in-clinic assessments are often too infrequently administered to reflect longitudinal changes in MS impairment that impact daily life. This work, therefore, explores how smartphones can administer daily two-minute walking assessments to monitor PwMS physical function at home.

MethodsRemotely collected smartphone inertial sensor data was transformed through state-of-the-art Deep Convolutional Neural Networks, to estimate a participants daily ambulatory-related disease severity, longitudinally over a 24-week study.

ResultsThis study demonstrated that smartphone-based ambulatory severity outcomes could accurately estimate MS level of disability, as measured by the EDSS score (r2: 0.56,p <0.001). Furthermore, longitudinal severity outcomes were shown to accurately reflect individual participants level of disability over the study duration.

ConclusionSmartphone-based assessments, that can be performed by patients from their home environments, could greatly augment standard in-clinic outcomes for neurodegenerative diseases. The ability to understand the impact of disease on daily-life between clinical visits, through objective digital outcomes, paves the way forward to better measure and identify signs of disease progression that may be occurring out-of-clinic, to monitor how different patients respond to various treatments, and to ultimately enable the development of better, and more personalised care.


sentences:
Association of Workload and Practice of Respectful Maternity Care Among the Healthcare Providers, Before and During the COVID-19 Pandemic in South Western Nepal: A Cross-Sectional Study IntroductionRespectful maternity care is an approach that involves respecting womens belief, choices, emotions, and dignity during the childbirth process. As the workload among maternity care workforce affects intrapartum quality care, respectful maternity care might have also been affected, particularly during the pandemic. Thus, this study was conducted to examine the association between workload among healthcare providers and their practice of respectful maternity care, before and during the pandemic.

MethodsA cross-sectional study was conducted in South Western Nepal. A total of 267 healthcare providers from 78 birthing centers were included. Data collection was done through telephone interviews. The exposure variable was workload among the healthcare providers, and the outcome variable was respectful maternity care practice before and during the COVID-19 pandemic. Multilevel mixed-effect linear regression was used to examine the association.

ResultsThe median client-provider ratio before and during the pandemic was 21.7 and 13.0, respectively. The mean score of respectful maternity care practice was 44.5 (SD 3.8) before the pandemic, which was decreased to 43.6 (SD 4.5) during the pandemic. Client-provider ratio was negatively associated with respectful maternity care practice for both times; before (Coef. -5.16; 95% CI -8.41 to -1.91) and during (Coef. -7.47; 95% CI -12.72 to -2.23) the pandemic.

ConclusionsWhile a higher client-provider was associated with a lower respectful maternity care practice score both before and during the COVID-19 pandemic, the coefficient was larger during the pandemic. Therefore, workload among the healthcare providers should be considered before the implementation of respectful maternity care, and more attention should be given during the pandemic.


sentences: Abdominal Imaging Associates Body Composition with COVID-19 Severity The main drivers of COVID-19 disease severity and the impact of COVID-19 on long-term health after recovery are yet to be fully understood. Medical imaging studies investigating COVID-19 to date have mostly been limited to small datasets and post-hoc analyses of severe cases. The UK Biobank recruited recovered SARS-CoV-2 positive individuals (n=967) and matched controls (n=913) who were extensively imaged prior to the pandemic and underwent follow-up scanning. In this study, we investigated longitudinal changes in body composition, as well as the associations of pre-pandemic image-derived phenotypes with COVID-19 severity. Our longitudinal analysis, in a population of mostly mild cases, associated a decrease in lung volume with SARS-CoV-2 positivity. We also observed that increased visceral adipose tissue and liver fat, and reduced muscle volume, prior to COVID-19, were associated with COVID-19 disease severity. Finally, we trained a machine classifier with demographic, anthropometric and imaging traits, and showed that visceral fat, liver fat and muscle volume have prognostic value for COVID-19 disease severity beyond the standard demographic and anthropometric measurements. This combination of image-derived phenotypes from abdominal MRI scans and ensemble learning to predict risk may have future clinical utility in identifying populations at-risk for a severe COVID-19 outcome.

labels: infectious diseases


sentences:
Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection BackgroundCommunity-directed treatment with 150 {micro}g/kg ivermectin (CDTI), the current control strategy, is insufficient for eliminating Onchocerca volvulus transmission across sub-Saharan Africa. Our study in CDTI-naive areas in Nord Kivu and Ituri (Democratic Republic of the Congo (DRC), Lofa County (Liberia) and Nkwanta district (Ghana) showed that a single 8 mg moxidectin dose reduced skin microfilariae density (microfilariae/mg skin, SmfD) better and for longer than a single 150{micro}g/kg ivermectin dose.

Methodology/Principal FindingsWe analysed drug efficacy by study area and pre-treatment SmfD (intensity of infection, IoI). Four and three IoI categories were defined for across-study and by-study area analyses, respectively. We used a general linear model to analyse SmfD 1, 6, 12 and 18 months post-treatment, a logistic model to determine the odds of undetectable SmfD from month 1 to month 6 (UD1-6), month 12 (UD1-12) and month 18 (UD1-18), and descriptive statistics to quantitate inter-interindividual response differences. Twelve months post-treatment, treatment differences were 92.9%, 90.1%, 86.8% and 84.5% in Nord Kivu, Ituri, Lofa and Nkwanta, and 74.1%, 84.2%, 90.0% and 95.4% for participants with SmfD 10-20, [≥]20-<50, [≥]50-<80, [≥]80, respectively. Ivermectins efficacy was lower in Ituri and Nkwanta than Nord Kivu and Lofa (p[≤]0.002) and moxidectins efficacy lower in Nkwanta than Nord Kivu, Ituri and Lofa (p<0.006). Odds ratios for UD1-6, UD1-12 or UD1-18 after moxidectin versus ivermectin treatment exceeded 7.0. Suboptimal response (SmfD 12 months post-treatment >40% of pre-treatment SmfD) occurred in 0%, 0.3%, 1.6% and 3.9% of moxidectin and 12.1%, 23.7%, 10.8% and 28.0% of ivermectin treated participants in Nord Kivu, Ituri, Lofa and Nkwanta, respectively.

Conclusions/significanceThe benefit of moxidectin vs ivermectin treatment increased with pre-treatment IoI. The possibility that parasite populations in different areas have different drug susceptibility without prior ivermectin selection pressure needs to be considered and further investigated.

Author SummaryOnchocerciasis or river blindness is a parasitic disease primarily in sub-Saharan Africa and Yemen. It can cause debilitating morbidity including severe itching, skin changes, visual impairment and even blindness. Many years of control efforts, today primarily based on mass administration of ivermectin (MDA) in endemic communities, have reduced morbidity and the percentage of infected individuals so that elimination of parasite transmission is now planned. WHO estimated that in 2020 more than 239 million people required MDA. Ivermectin may not be sufficiently efficacious to achieve elimination everywhere. Our study in areas in Liberia, Ghana and the Democratic Republic of the Congo where MDA had not been implemented yet showed that moxidectin reduced parasite levels in the skin better and for longer than ivermectin. Here we show that people with higher numbers of parasites in the skin benefit more from moxidectin treatment than those with lower numbers and that the efficacy of ivermectin and moxidectin differs between study areas. Provided WHO and countries include moxidectin in guidelines and policies, this information could help decisions on when and where to use moxidectin.


sentences:
Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer ObjectivesAntigen-based rapid diagnostic tests (Ag-RDTs) have been widely used for the detection of SARS-CoV-2 during the Covid-19 pandemic. In settings of low disease prevalence, such as asymptomatic community testing, national guidelines recommend molecular confirmation of positive Ag-RDT results. This often requires patients to be recalled for repeat specimen recollection and subsequent testing in reference laboratories. This project assessed the use of a point-of-care molecular method for SARS-CoV-2 detection on-site at a volunteer-led asymptomatic community testing site, using the residual test buffer (RTB) from positive Ag-RDTs.

MethodsThe Abbott COVID-19 ID NOW assay was performed on RTB from two Ag-RDTs: the Abbott Panbio COVID-19 Ag Rapid Test Device and the BTNX Rapid Response COVID-19 Antigen Rapid Test Device. All RTBs were tested using real-time RT-PCR at a reference laboratory using the ThermoFisher TaqPath COVID-19 Combo kit which was used to assign positive Ag-RDTs results as true or false positives. Analytical specificity of the ID NOW was assessed with a panel of various respiratory organisms.

ResultsOf 419 positive Ag-RDTs from 5148 tests performed, ID NOW testing of the RTB was positive in 100% of the samples characterized as true positives by RT-PCR. No SARS-CoV-2 detections by ID NOW were observed from 10 specimens characterized as false positive Ag-RDTs, or from contrived specimens with various respiratory organisms.

ConclusionsThe use of on-site molecular testing on RTB provides a suitable option for rapid confirmatory testing of positive Ag-RDTs, thereby obviating the need for specimen recollection for molecular testing at local reference laboratories.


sentences:
SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala BackgroundDuring the COVID-19 pandemic, serological tests to screen populations have provided better estimates of the cumulative incidence of infection. This study evaluated the seroprevalence of SARS-CoV-2 in agricultural workers in rural Guatemala, their COVID-19 vaccine uptake and vaccination attitudes.

MethodsA cross-sectional study was undertaken from August to November of 2021, in agricultural workers at a sugar plantation in Guatemala. A questionnaire was used to collect demographic, previous COVID-19 infection, vaccination, and attitudes toward vaccination. Serological testing was performed to detect SARS-CoV-2 IgM and IgG.

ResultsOf the 4,343 study participants, 1,279 (29.4%) were seropositive for SARS-CoV-2 compared to 2.3% who reported previous COVID-19 infection. COVID-19 vaccine coverage was 85% for the first dose and 21.9% for second dose. Vaccine refusal was 0.6%, and 13.9% expressed some degree of vaccine hesitancy. Vaccine hesitant workers or those refusing were less likely to have had the COVID-19 vaccine. Main reasons to get the vaccine were to protect family, coworkers, and community.

ConclusionAgricultural workers in countries like Guatemala have suffered a high incidence of asymptomatic and undetected SARS-CoV-2 infection. Most have received the COVID-19 vaccine, but there are moderate degrees of vaccine hesitancy that require better public health information to overcome it.


sentences:
SARS-CoV-2 Infection Breakthrough among the non-vaccinated and vaccinated: a Real World Evidence study based on Big Data BackgroundSARS-CoV-2 infection after vaccination can occur because COVID-19 vaccines do not offer 100% protection. The aim of this study was to assess vaccination coverage among people nasopharyngeal swabs, disease symptoms and type of hospitalisation (Intensive Care Unit) between the non-vaccinated and the effective dose vaccinated and to evaluate vaccination trend over time.

MethodsA retrospective cohort study was carried out among people tested positive for COVID-19 in Campania Region using collected information from Health Information System of Campania Region (Sinfonia).

The status of vaccination was assess according to the following timetable: "non-vaccinated"; "Ineffective dose" vaccination; "Effective dose" vaccination.

Univariate and multivariate logistic regression models were conducted to evaluate the association between Intensive Care Unit (ICU) to COVID-19 and gender, age groups and vaccine.

To determine vaccine coverage in subjects who received an effective dose, trend changes over time were investigated using segmented linear regression models and breakpoints estimations.

Vaccination coverage was assessed by analysing the trend in the percentage of covid 19 positive subjects in the 9 months after vaccination with an effective dose stratified by age group and type of vaccine. Statistical analyses were performed using R platform

ResultsA significant association with the risk of hospitalisation in Intensive Care Unit was the vaccination status of the subjects: subjects with ineffective dose (adjusted OR: 3.68) and subjects no-vaccination (adjusted OR: 7.14) were at three- and seven-times higher risk of hospitalisation in Intensive Care Unit, respectively, than subjects with an effective dose.

Regarding subjects with an effective dose of vaccine, the vaccines ability to protect against infection in the months following vaccination decreased.

The first breakpoints is evident five months after vaccination ({beta} =1.441, p<0.001). This increase was most evident after the seventh month after vaccination ({beta} =3.110, p<0.001).

ConclusionsCOVID19 vaccines protect from symptomatic infection by significantly reducing the risk of ICU hospitalization for severe disease. However, it seems they have trend to decrease their fully protection against SARS-COV-2 after five months regardless age, sex or type of vaccine. Therefore it seems clear that those not undergoing vaccine had higher risk to develop clinically significant disease and being at risk of ICU stay. Thus, considering highest percentage of asymptomatic patients and that few data about their capacity to transmit SARS-CoV-2, third dose vaccination should be introduced as soon as possible while awaiting antivirals.Finally, a surveillance approach based on the use of integrated BIG Data system to match all clinical conditions too, offer a precise and real analysis with low incidence of errors in the categorization of subjects.


sentences:
Exploring facilitators for a transition from alternative and complementary therapies to evidence-based treatments in Ugandan first-episode psychosis patients. IntroductionMost patients with psychotic disorders in Africa initially use alternative and complementary therapies leading to delays accessing evidence-based treatments. This delay, known as the duration of untreated psychosis (DUP), is associated with suboptimal response and reduced efficacy in short-term and long-term outcomes. In this study, we explore facilitators for transitioning from alternative and complementary therapies to evidence-based treatments for psychotic disorders, comparing these facilitators between patients and their caregivers.

MethodsThe study was conducted at Butabika hospital in Kampala, Uganda. Participants included patients with first-episode psychosis who had used alternative and complementary therapies and their caregivers. An exploratory qualitative design using in-depth interviews was performed with thematic analysis used to analyze the data.

ResultsWe interviewed eight patients and eight caregivers. The key themes that led to a switch were the high cost of alternative therapies, a desire to know the cause of the illness, seeking better care and the influence of friends and community members. Themes were similar among the participants and their caregivers except for stigma, which was only found among the caregivers.

ConclusionsThe reasons for transitioning from alternative and complementary therapies to evidence-based treatments are similar between patients and caregivers, except for stigma that is a more important factor for transition among caregivers. Since this was an exploratory study, additional research with a larger sample and more diverse population would enable a deeper understanding of these factors and guide the development of interventions to reduce DUP and improve outcomes for psychotic disorders.


sentences: The immune profile of Major Dysmood Disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach Major depressive disorder and a major depressive episode (MDD/MDE) are characterized by activation of the immune-inflammatory response system (IRS) and the compensatory immune-regulatory system (CIRS). In MDD/MDE, recent precision nomothetic psychiatry studies discovered a new endophenotype class namely Major Dysmood Disorder, a new pathway phenotype namely reoccurrence of illness (ROI), and a new model of the phenome of depression. The aim of the present study is to examine the association between ROI, the phenome of depression, and MDMDs features and IRS, CIRS, M1, T helper (Th)1, Th2, Th17, Tregulatory, and growth factor (GF) profiles. Culture supernatants of unstimulated and stimulated (5 g/mL of PHA and 25 g/mL of LPS) diluted whole blood of 30 MDD/MDE patients and 20 controls were assayed for cytokines/GF using the LUMINEX assay. MDMD was characterized by increased M1, Th1, Th2, Th17, Treg, IRS, CIRS, neurotoxicity and GF profiles. Factor analysis shows that ROI features and immune-GF profiles may be combined into one a new pathway phenotype (an extracted latent vector). ROI, lifetime and recent suicidal behaviors, and severity of depression are significantly associated with immunotoxicity and GF profiles. Around 80.0% of the variance in the phenome is predicted by ROI and neurotoxicity or the IRS / CIRS ratio. The molecular pathways underpinning ROI-associated sensitization of immune/growth networks are transmembrane receptor protein kinase triggered STAT protein phosphorylation, TLR/NF-{kappa}B, JAK-STAT, and the main proliferation/survival PI3K/Akt/RAS/MAPK pathway. In conclusion, MDMDs heightened immune responses are the consequence of ROI-associated sensitization combined with immunostimulatory triggers.


sentences: An atlas of trait associations with resting-state and task-evoked human brain functional architectures in the UK Biobank medRxiv has withdrawn this manuscript because it was submitted and made public without the full consent of all the authors. Therefore, this work should not be cited as reference for the project. If you have any questions, please contact the corresponding author.


sentences: LABELLING HUMAN KINEMATICS DATA USING CLASSIFICATION MODELS The goal of this study is to develop a classification model that can accurately and efficiently label human kinematics data. Kinematics data provides information about the movement of individuals by placing sensors on the human body and tracking their velocity, acceleration and position in three dimensions. These data points are available in C3D format that contains numerical data transformed from 3D data captured from the sensors. The data points can be used to analyse movements of injured patients or patients with physical disorders. To get an accurate view of the movements, the datasets generated by the sensors need to be properly labelled. Due to inconsistencies in the data capture process, there are instances where the markers have missing data or missing labels. The missing labels are a hindrance in motion analysis as it introduces noise and produces incomplete datapoints of sensors positioning in 3 dimensional space. Labelling the data manually introduces substantial effort in the analysis process. In this paper, we will describe approaches to pre-process the kinematics data from its raw format and label the data points with missing markers using classification models.

labels: rehabilitation medicine and physical therapy


sentences:
Gestational SARS-CoV-2 infection is associated with placental expression of immune and trophoblast genes IntroductionMaternal SARS-CoV-2 infection during pregnancy is associated with adverse pregnancy outcomes and can have effects on the placenta, even in the absence of severe disease or vertical transmission to the fetus. This study aimed to evaluate histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy.

MethodsWe performed a study of 45 pregnant participants from the Generation C prospective cohort study at the Mount Sinai Health System in New York City. We compared histologic features and the expression of 48 immune and trophoblast genes in placentas delivered from 15 SARS-CoV-2 IgG antibody positive and 30 IgG SARS-CoV-2 antibody negative mothers. Statistical analyses were performed using Fishers exact tests, Spearman correlations and linear regression models.

ResultsThe median gestational age at the time of SARS-CoV-2 IgG serology test was 35 weeks. Two of the IgG positive participants also had a positive RT-PCR nasal swab at delivery. 82.2% of the infants were delivered at term ([≥]37 weeks), and gestational age at delivery did not differ between the SARS-CoV-2 antibody positive and negative groups. No significant differences were detected between the groups in placental histopathology features. Differential expression analyses revealed decreased expression of two trophoblast genes (PSG3 and CGB3) and increased expression of three immune genes (CXCL10, TLR3 and DDX58) in placentas delivered from SARS-CoV-2 IgG positive participants.

DiscussionSARS-CoV-2 infection during pregnancy is associated with gene expression changes of immune and trophoblast genes in the placenta at birth which could potentially contribute to long-term health effects in the offspring.

labels: sexual and reproductive health